Also, a negative correlation between gal-3-binding sites and sTn expression was also observed in gastric cancer-derived metastasis, (Figure 8A) that was further confirmed in a double immunofluorescence assay using anti-sTn antibody and human recombinant gal-3 previously labeled with -Dy488 (Gal-3-Dy488) (Figure 8B). The gene discussed is EEF1A2; the disease is gastric cancer.